1-7 of 7
Philippe Moreau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma

Clinical Trials & Observations
Heinz Ludwig, Nikhil C. Munshi, Evangelos Terpos, Ilvy Schweitzer, Noopur Raje, Philippe Moreau, Ajay Nooka
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4979–4982.
https://doi.org/10.1182/bloodadvances.2024013461
Published: 2024
Includes: Supplemental data
Journal Articles

Response to 'A call to improve reporting of infection events in clinical treatment trials...'

Clinical Trials & Observations
Heinz Ludwig, Nikhil C. Munshi, Evangelos Terpos, Noopur Raje, Philippe Moreau, Ajay K. Nooka
Journal: Blood Advances
Blood Adv bloodadvances.2024014102.
https://doi.org/10.1182/bloodadvances.2024014102
Published: 2024
Journal Articles

Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications

Eric Letouzé, Philippe Moreau, Nikhil Munshi, Mehmet Samur, Stéphane Minvielle, Cyrille Touzeau
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2952–2959.
https://doi.org/10.1182/bloodadvances.2023012354
Published: 2024
Journal Articles

Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX

Clinical Trials & Observations
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z. Orlowski, Sung-Soo Yoon, Saad Z. Usmani, Katja Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J. Blake Bartlett, Robin Carson, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2024) 8 (2): 388–398.
https://doi.org/10.1182/bloodadvances.2023010579
Published: 2024
Includes: Supplemental data
Journal Articles

Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma

Clinical Trials & Observations
Thomas Martin, Joseph Mikhael, Roman Hajek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin, Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatiana Konstantinova, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, Philippe Moreau
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4506–4515.
https://doi.org/10.1182/bloodadvances.2021006713
Published: 2022
Journal Articles

p53 regulates CD46 expression and measles virus infection in myeloma cells

Anne Lok, Geraldine Descamps, Benoit Tessoulin, David Chiron, Marion Eveillard, Catherine Godon, Yannick Le Bris, Astrid Vabret, Celine Bellanger, Laurent Maillet, Sophie Barillé-Nion, Marc Gregoire, Jean-François Fonteneau, Steven Le Gouill, Philippe Moreau, Frederic Tangy, Martine Amiot, Agnes Moreau-Aubry, Catherine Pellat-Deceunynck
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3492–3505.
https://doi.org/10.1182/bloodadvances.2018025106
Published: 2018
Includes: Supplemental data
Journal Articles

Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials

Clinical Trials & Observations
Ajai Chari, A. Keith Stewart, Stuart D. Russell, Philippe Moreau, Joerg Herrmann, Jose Banchs, Roman Hajek, John Groarke, Alexander R. Lyon, George N. Batty, Sunhee Ro, Mei Huang, Karim S. Iskander, Daniel Lenihan
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1633–1644.
https://doi.org/10.1182/bloodadvances.2017015545
Published: 2018
Includes: Supplemental data